Glioblastoma is the most common primary CNS tumor and is the most aggressive neoplasm among gliomas. Glioblastoma represents a highly unmet medical need due to its dismal prognosis, meaningful disability and lack of new agents since temozolomide concurrent with and adjuvant to radiotherapy became the standard therapy

The burden of oncology promises not kept in glioblastoma / Lamberti G.; Franceschi E.; Brandes A.A.. - In: FUTURE NEUROLOGY. - ISSN 1479-6708. - ELETTRONICO. - 13:1(2018), pp. 1-4. [10.2217/fnl-2017-0033]

The burden of oncology promises not kept in glioblastoma

Lamberti G.;
2018

Abstract

Glioblastoma is the most common primary CNS tumor and is the most aggressive neoplasm among gliomas. Glioblastoma represents a highly unmet medical need due to its dismal prognosis, meaningful disability and lack of new agents since temozolomide concurrent with and adjuvant to radiotherapy became the standard therapy
2018
The burden of oncology promises not kept in glioblastoma / Lamberti G.; Franceschi E.; Brandes A.A.. - In: FUTURE NEUROLOGY. - ISSN 1479-6708. - ELETTRONICO. - 13:1(2018), pp. 1-4. [10.2217/fnl-2017-0033]
Lamberti G.; Franceschi E.; Brandes A.A.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/959028
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact